| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |